The association between circulating MicroRNA levels and coronary endothelial function

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Widmer, R Jay ^a   Chung, Woo Young ^a   Herrmann, Joerg ^a   Jordan, Kyra L ^a   Lerman, Lilach O ^a   Lerman, Amir ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 133; MICRORNA 92A; UNCLASSIFIED DRUG; MIRN133 MICRORNA, HUMAN; MIRN92 MICRORNA, HUMAN;

ADULT; ANGIOCARDIOGRAPHY; AORTA SINUS; ARTERY DIAMETER; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY ENDOTHELIAL DYSFUNCTION; CORONARY SINUS; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FEMALE; HEART CATHETERIZATION; HEART FUNCTION TEST; HUMAN; ISCHEMIC HEART DISEASE; MALE; RNA ISOLATION; BLOOD; GENE EXPRESSION REGULATION; GENETICS; HEART; MIDDLE AGED; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

CORONARY ARTERY DISEASE; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION REGULATION; HEART; HUMANS; MALE; MICRORNAS; MIDDLE AGED;

EID: 84907938582     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109650     Document Type: Article

References (42)

1. Lee R, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854.
2. Bartel D (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
3. Calin G, Dumitru CD, Shimizu M, Bichi R, Zupo S, et al. (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99: 15524-15529.
4. Taurino C, Miller WH, McBride MW, McClure JD, Khanin R, et al. (2010) Gene expression profiling in whole blood of patients with coronary artery disease. Clin Sci (Lond) 119: 335-343.
5. Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, et al. (2007) Altered microRNA expression in human heart disease. Physiol Genomics 31: 367-373.
6. Lorenzen J, Kielstein JT, Hafer C, Gupta SK, Kümpers P, et al. (2011) Circulating miR-210 predicts survival in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol 6: 1540-1546.
7. van Rooij E, Olson EN (2007) MicroRNAs: Powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest 117: 2369-2376.
8. Fang Y, Davies PF (2012) Site-specific microRNA-92a regulation of Kruppellike factors 4 and 2 in atherosusceptible endothelium. Arterioscler Thromb Vasc Biol 32: 979-987.
9. Tréguer K, Heinrich EM, Ohtani K, Bonauer A, Dimmeler S (2012) Role of the microRNA-17-92 cluster in the endothelial differentiation of stem cells. J Vasc Res 49: 447-460.
10. Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, et al. (2009) Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2: ra81.
11. Harris T, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ (2008) MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci U S A 105: 1516-1521.
12. Mocharla P, Briand S, Giannotti G, Dörries C, Jakob P, et al. (2013) AngiomiR- 126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: role for proangiogenic effects and alterations in type 2 diabetics. Blood 121: 226-236.
13. Xu Q, Seeger FH, Castillo J, Iekushi K, Boon RA, et al. (2012) Micro-RNA-34a contributes to the impaired function of bone marrow-derived mononuclear cells from patients with cardiovascular disease. J Am Coll Cardiol 59: 2107-2117.
14. Torella D, Iaconetti C, Catalucci D, Ellison GM, Leone A, et al. (2011) MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circ Res 109: 880-893.
15. Callis T, Pandya K, Seok HY, Tang RH, Tatsuguchi M, et al. (2009) MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 119: 2772-2786.
16. Tu Y, Wan L, Fan Y, Wang K, Bu L, et al. (2013) Ischemic Postconditioning- Mediated miRNA-21 Protects against Cardiac ischemia/reperfusion Injury via PTEN/Akt Pathway. PLoS One 8: E75872.
17. Wu C, Gong Y, Yuan J, Zhang W, Zhao G, et al. (2012) microRNA-181a represses ox-LDL-stimulated inflammatory response in dendritic cell by targeting c-Fos. J Lipid Res 53: 2355-2363.
18. Coleman C, Lightell DJ Jr, Moss SC, Bates M, Parrino PE (2013) Elevation of miR-221 and -222 in the internal mammary arteries of diabetic subjects and normalization with metformin. Mol Cell Endocrinol 374: 125-129.
19. Liu X, Cheng Y, Yang J, Xu L, Zhang C (2012) Cell-specific effects of miR-221/222 in vessels: Molecular mechanism and therapeutic application. J Mol Cell Cardiol 52: 245-255.
20. Cordes K, Sheehy NT, White MP, Berry EC, Morton SU, et al. (2009) miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460: 705-710.
21. Nazari-Jahantigh M, Wei Y, Noels H, Akhtar S, Zhou Z, et al. (2012) MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J Clin Invest 122: 4190-4202.
22. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, et al. (2010) Circulating microRNAs in patients with coronary artery disease. Circ Res 107: 677-684.
23. De Rosa S, Fichtlscherer S, Lehmann R, Assmus B, Dimmeler S (2011) Transcoronary concentration gradients of circulating microRNAs. Circulation 124: 1936-1944.
24. Bonetti P, Lerman LO, Lerman A (2003) Endothelial dysfunction: A marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23: 168-175.
25. Lerman A, Zeiher AM (2005) Endothelial function: cardiac events. Circulation 111: 363-368.
26. Rubinshtein R, Kuvin JT, Soffler M, Lennon RJ, Lavi S, et al. (2010) Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. European Heart Journal 31: 11422-1148.
27. Targonski P, Bonetti PO, Pumper GM, Higano ST, Holmes DR Jr (2003) Coronary Endothelial Dysfunction Is Associated With an Increased Risk of Cerebrovascular Events. Circulation 107: 2805-2809.
28. Yoon M, Reriani M, Mario G, Rihal C, Gulati R, et al. (2013) Long-term endothelin receptor antagonism attenuates coronary plaque progression in patients with early atherosclerosis. Int J Cardiol S0167-5273: 01629-01624.
29. Widmer R, Flammer A, Herrmann J, Rodriguez-Porcel M, Wan J, et al. (2012) Circulating humanin levels are associated with preserved coronary endothelial function. Am J Physiol Heart Circ Physiol [Epub ahead of print].
30. Han S, Bae JH, Holmes DR Jr, Lennon RJ, Eeckhout E, et al. (2008) Sex differences in atheroma burden and endothelial function in patients with early coronary atherosclerosis. Eur Heart J 29: 1359-1369.
31. Hasdai D, Gibbons RJ, Holmes DR Jr, Higano ST, Lerman A (1997) Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 96: 3390-3395.
32. Reriani M, Flammer AJ, Jama A, Lerman LO, Lerman A (2012) Novel functional risk factors for the prediction of cardiovascular events in vulnerable patients following acute coronary syndrome. Circ J 76: 778-783.
33. Lavi S, McConnell JP, Rihal CS, Prasad A, Mathew V, et al. (2007) Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: Association with early coronary atherosclerosis and endothelial dysfunction in humans. Circulation 115: 2715-2721.
34. Lavi S, Yang EH, Prasad A, Mathew V, Barsness GW, et al. (2008) The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans. Hypertension 51: 127-133.
35. Suwaidi J, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr (2000) Longterm follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101: 948-954.
36. Gossl M, Modder UI, Atkinson EJ, Lerman A, Khosla S (2008) Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis. J Am Coll Cardiol 52: 1314-1325.
37. Mitchell P, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
38. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, et al. (2009) MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324: 1710-1713.
39. Iaconetti C, Polimeni A, Sorrentino S, Sabatino J, Pironti G, et al. (2012) Inhibition of miR-92a increases endothelial proliferation and migration in vitro as well as reduces neointimal proliferation in vivo after vascular injury. Basic Res Cardiol 107: 296.
40. He B, Xiao J, Ren AJ, Zhang YF, Zhang H, et al. (2011) Role of miR-1 and miR-133a in myocardial ischemic postconditioning. J Biomed Sci 18: 22.
41. Li R, Yan G, Li Q, Sun H, Hu Y, et al. (2012) MicroRNA-145 Protects Cardiomyocytes against Hydrogen Peroxide (H(2)O(2))-Induced Apoptosis through Targeting the Mitochondria Apoptotic Pathway. PLoS One 7: E44907.
42. Willeit P, Zampetaki A, Dudek K, Kaudewitz D, King A, et al. (2013) Circulating microRNAs as novel biomarkers for platelet activation. Circ Res 112: 5952600.